New Zealand markets close in 5 hours 21 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.80000.0000 (0.00%)
At close: 04:00PM EDT
1.8000 0.00 (0.00%)
After hours: 07:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 273.76M
Enterprise value 385.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.04
Price/book (mrq)12.60
Enterprise value/revenue 2.82
Enterprise value/EBITDA -1.55

Trading information

Stock price history

Beta (5Y monthly) 1.80
52-week change 344.00%
S&P500 52-week change 320.52%
52-week high 33.9300
52-week low 30.5000
50-day moving average 32.5788
200-day moving average 32.5598

Share statistics

Avg vol (3-month) 32.36M
Avg vol (10-day) 31.53M
Shares outstanding 5151.67M
Implied shares outstanding 6151.67M
Float 8115.73M
% held by insiders 10.72%
% held by institutions 186.91%
Shares short (15 Aug 2024) 435.96M
Short ratio (15 Aug 2024) 412.81
Short % of float (15 Aug 2024) 430.66%
Short % of shares outstanding (15 Aug 2024) 423.71%
Shares short (prior month 15 Jul 2024) 435.66M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 313 Jan 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin -35.29%
Operating margin (ttm)-17.89%

Management effectiveness

Return on assets (ttm)-8.58%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)136.36M
Revenue per share (ttm)0.88
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA -26.02M
Net income avi to common (ttm)-48.13M
Diluted EPS (ttm)-0.2500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)67.35M
Total cash per share (mrq)0.44
Total debt (mrq)178.71M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.38
Book value per share (mrq)-0.25

Cash flow statement

Operating cash flow (ttm)-20.84M
Levered free cash flow (ttm)285k